IL164018A0 - Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serineprotease factor xa - Google Patents
Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serineprotease factor xaInfo
- Publication number
- IL164018A0 IL164018A0 IL16401803A IL16401803A IL164018A0 IL 164018 A0 IL164018 A0 IL 164018A0 IL 16401803 A IL16401803 A IL 16401803A IL 16401803 A IL16401803 A IL 16401803A IL 164018 A0 IL164018 A0 IL 164018A0
- Authority
- IL
- Israel
- Prior art keywords
- factor
- inhibitors
- cyclopropylglycinyl
- serineprotease
- piperidin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36852302P | 2002-04-01 | 2002-04-01 | |
| PCT/US2003/007794 WO2003084929A1 (en) | 2002-04-01 | 2003-03-24 | Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL164018A0 true IL164018A0 (en) | 2005-12-18 |
Family
ID=28791889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16401803A IL164018A0 (en) | 2002-04-01 | 2003-03-24 | Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serineprotease factor xa |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US7166606B2 (de) |
| EP (1) | EP1492767B1 (de) |
| JP (1) | JP2005531529A (de) |
| KR (1) | KR20040094892A (de) |
| CN (1) | CN1288135C (de) |
| AT (1) | ATE303990T1 (de) |
| AU (1) | AU2003218147A1 (de) |
| BR (1) | BR0308870A (de) |
| CA (1) | CA2478340A1 (de) |
| CR (1) | CR7497A (de) |
| DE (1) | DE60301569T2 (de) |
| DK (1) | DK1492767T3 (de) |
| EA (1) | EA007300B1 (de) |
| EC (1) | ECSP045329A (de) |
| ES (1) | ES2248737T3 (de) |
| HK (1) | HK1070363A1 (de) |
| HR (1) | HRP20040900B1 (de) |
| IL (1) | IL164018A0 (de) |
| MX (1) | MXPA04009640A (de) |
| NO (1) | NO20044688L (de) |
| NZ (1) | NZ535402A (de) |
| PL (1) | PL373066A1 (de) |
| UA (1) | UA76849C2 (de) |
| WO (1) | WO2003084929A1 (de) |
| ZA (1) | ZA200407418B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6834308B1 (en) | 2000-02-17 | 2004-12-21 | Audible Magic Corporation | Method and apparatus for identifying media content presented on a media playing device |
| EP1490767B1 (de) | 2001-04-05 | 2014-06-11 | Audible Magic Corporation | Copyright-erkennung und schutzsystem und verfahren |
| US8972481B2 (en) | 2001-07-20 | 2015-03-03 | Audible Magic, Inc. | Playlist generation method and apparatus |
| DE102014108210A1 (de) | 2014-06-11 | 2015-12-17 | Dietrich Gulba | Rodentizid |
| WO2018093716A1 (en) * | 2016-11-18 | 2018-05-24 | Merck Sharp & Dohme Corp. | FACTOR XIIa INHIBITORS |
| EP4070658A1 (de) | 2021-04-06 | 2022-10-12 | BIORoxx GmbH | Verwendung von blutgerinnungshemmenden verbindungen als rodentizide |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999011658A1 (en) | 1997-08-29 | 1999-03-11 | Proteus Molecular Design Ltd. | Meta-benzamidine derivatives as serin protease inhibitors |
| CA2383008A1 (en) | 1999-06-14 | 2000-12-21 | Amanda Jane Lyons | Compounds |
| WO2000076971A2 (en) | 1999-06-14 | 2000-12-21 | Eli Lilly And Company | Serine protease inhibitors |
| GB0030304D0 (en) * | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
| GB0030305D0 (en) | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
| GB0030303D0 (en) | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
| GB0030306D0 (en) | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
| TWI257389B (en) | 2001-06-12 | 2006-07-01 | Lilly Co Eli | Pharmaceutical compound |
| AU2002322396A1 (en) * | 2001-07-26 | 2003-02-17 | Eli Lilly And Company | 1-glycinyl-4 (methylpiperidin-4-yl) piperazines and -piperridines as factor xa antagonists |
-
2003
- 2003-03-24 JP JP2003582128A patent/JP2005531529A/ja active Pending
- 2003-03-24 CN CNB038074141A patent/CN1288135C/zh not_active Expired - Fee Related
- 2003-03-24 MX MXPA04009640A patent/MXPA04009640A/es active IP Right Grant
- 2003-03-24 EP EP03714138A patent/EP1492767B1/de not_active Expired - Lifetime
- 2003-03-24 BR BR0308870-7A patent/BR0308870A/pt not_active IP Right Cessation
- 2003-03-24 ES ES03714138T patent/ES2248737T3/es not_active Expired - Lifetime
- 2003-03-24 DK DK03714138T patent/DK1492767T3/da active
- 2003-03-24 IL IL16401803A patent/IL164018A0/xx unknown
- 2003-03-24 WO PCT/US2003/007794 patent/WO2003084929A1/en active IP Right Grant
- 2003-03-24 UA UA20041008649A patent/UA76849C2/uk unknown
- 2003-03-24 AU AU2003218147A patent/AU2003218147A1/en not_active Abandoned
- 2003-03-24 US US10/486,138 patent/US7166606B2/en not_active Expired - Fee Related
- 2003-03-24 KR KR10-2004-7015486A patent/KR20040094892A/ko not_active Application Discontinuation
- 2003-03-24 NZ NZ535402A patent/NZ535402A/en unknown
- 2003-03-24 AT AT03714138T patent/ATE303990T1/de not_active IP Right Cessation
- 2003-03-24 EA EA200401290A patent/EA007300B1/ru not_active IP Right Cessation
- 2003-03-24 CA CA002478340A patent/CA2478340A1/en not_active Abandoned
- 2003-03-24 DE DE60301569T patent/DE60301569T2/de not_active Expired - Fee Related
- 2003-03-24 PL PL03373066A patent/PL373066A1/xx unknown
-
2004
- 2004-09-15 ZA ZA200407418A patent/ZA200407418B/en unknown
- 2004-09-24 CR CR7497A patent/CR7497A/es unknown
- 2004-09-29 EC EC2004005329A patent/ECSP045329A/es unknown
- 2004-09-30 HR HR20040900A patent/HRP20040900B1/xx not_active IP Right Cessation
- 2004-10-29 NO NO20044688A patent/NO20044688L/no not_active Application Discontinuation
-
2005
- 2005-04-11 HK HK05103052A patent/HK1070363A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ535402A (en) | 2006-02-24 |
| CA2478340A1 (en) | 2003-10-16 |
| EP1492767B1 (de) | 2005-09-07 |
| UA76849C2 (uk) | 2006-09-15 |
| ECSP045329A (es) | 2004-11-26 |
| WO2003084929A1 (en) | 2003-10-16 |
| KR20040094892A (ko) | 2004-11-10 |
| CR7497A (es) | 2005-01-17 |
| DE60301569T2 (de) | 2006-06-14 |
| EA200401290A1 (ru) | 2005-02-24 |
| ZA200407418B (en) | 2005-09-15 |
| DE60301569D1 (de) | 2005-10-13 |
| US7166606B2 (en) | 2007-01-23 |
| EA007300B1 (ru) | 2006-08-25 |
| ES2248737T3 (es) | 2006-03-16 |
| DK1492767T3 (da) | 2005-11-28 |
| CN1288135C (zh) | 2006-12-06 |
| JP2005531529A (ja) | 2005-10-20 |
| US20050096328A1 (en) | 2005-05-05 |
| BR0308870A (pt) | 2005-01-04 |
| AU2003218147A1 (en) | 2003-10-20 |
| HK1070363A1 (en) | 2005-06-17 |
| NO20044688L (no) | 2004-10-29 |
| HRP20040900B1 (en) | 2006-02-28 |
| ATE303990T1 (de) | 2005-09-15 |
| CN1642914A (zh) | 2005-07-20 |
| WO2003084929A8 (en) | 2004-05-21 |
| HRP20040900A2 (en) | 2004-12-31 |
| EP1492767A1 (de) | 2005-01-05 |
| MXPA04009640A (es) | 2005-01-11 |
| PL373066A1 (en) | 2005-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1091121A1 (en) | Substituted 2-aminotetralins for the treatment of depressions | |
| IS7718A (is) | Pýrrólídíndíónútskipt píperídín-þalasón sem PDE4 tálmar | |
| IS6902A (is) | N-setin heterósýklísk NMDA/NR2B mótlyf sem ekki eru arýl | |
| NO20054852L (no) | GFAT inhibitorer | |
| MX2007000505A (es) | Derivados de oxindol sustituidos y medicamentos que contienen los mismos. | |
| NO20061454L (no) | Compounds having CRTH2 antagonist activity | |
| AP1699A (en) | New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors | |
| MY136883A (en) | 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition | |
| MX2009002229A (es) | Benzotriazoles como moduladores de cinasas. | |
| NO20050828L (no) | lndol-3-svovelderivater | |
| NO20062256L (no) | Hydroksyalkylsubstituerte pyrido-7-pyrimidin-7-oner | |
| NO20070089L (no) | DPP-IV inhibitorer | |
| HK1070363A1 (en) | Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serineprotease factor xa | |
| NO20064351L (no) | Caspaseinhibitorer og anvendelser derav | |
| GB0314967D0 (en) | Piperazine derivatives | |
| MXPA03010205A (es) | Derivados de acido oxalico. | |
| DE602004018811D1 (de) | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren | |
| MY137876A (en) | Pharmaceutical compound | |
| MXPA05006957A (es) | Nuevos derivados de fosforamida. | |
| WO2003076429A3 (en) | Azepane derivatives and their use as atk1 inhibitors | |
| AU2002322396A1 (en) | 1-glycinyl-4 (methylpiperidin-4-yl) piperazines and -piperridines as factor xa antagonists | |
| TW200603806A (en) | Pharmaceutical compound | |
| SI1492767T1 (sl) | Dolocene 1-(d-ciklopropilglicinil)-4-(piperidin-4-il)piperazinske spojine kot inhibitorji faktorja xa serinske proteaze | |
| TW200519071A (en) | 3-aryl-2-cyano-3-hydroxy-acrylic acid derivatives |